When our eyes move during REM sleep, we’re gazing at things in the dream world our brains have created, according to a new study by UCSF researchers. The findings shed light not only into how we dream, but also into how our imaginations work.

A new UCSF study sheds light on the diversity within the most common type of pediatric liver tumor and suggests a way forward for more precise chemotherapy treatment.

A new variation of the CRISPR-Cas9 gene editing system makes it easier to re-engineer massive quantities of cells for therapeutic applications. The approach, developed at Gladstone Institutes and UC San Francisco (UCSF), lets scientists introduce especially long DNA sequences to precise locations in the genomes of cells at remarkably high efficiencies without the viral delivery systems that have traditionally been used to carry DNA into cells.

A newly installed mural titled “Peace Piece” stretches over seven stories of the parking garage at the corner of Third Street and Mariposa on UCSF’s Mission Bay campus. Created by San Francisco artist Kota Ezawa, it is an extension of the Michael J. Bishop Art Collection at Mission Bay.

T cells used in immunotherapy treatments can get exhausted and shut down by fighting cancer cells and tumors. Using a CRISPR-based edit on these cells’ genomes, researchers at UCSF and Gladstone Institutes have rendered the therapeutic cells more resilient against tumors.

A campuswide survey of members of the UCSF community finds that respondents are generally positive about the University’s working and learning environment overall with 70% indicating that they feel either “comfortable” or “very comfortable” while 11% feel “uncomfortable” or “very uncomfortable.”

According to a new UCSF study, screening for depression at the primary care level could dramatically increase the likelihood of treatment for those who are traditionally undertreated — racial and ethnic minority individuals, older adults, those with limited English proficiency and men.

Harold “Hal” Collard, MD, MS, a pulmonologist with deep roots at UCSF, has been named UCSF’s next Vice Chancellor for Research. He currently serves as director of the Clinical and Translational Sciences Institute (CTSI) and associate vice chancellor for Clinical Research.